The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients

E. Rovkina, A. Emelyanov, L. M. DuBuske (St. Petersburg, Russian Federation; Gardner, United States Of America)

Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Session: Monitoring airway inflammation – exhaled markers vs induced sputum
Session type: Oral Presentation
Number: 738
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Rovkina, A. Emelyanov, L. M. DuBuske (St. Petersburg, Russian Federation; Gardner, United States Of America). The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients. Eur Respir J 2006; 28: Suppl. 50, 738

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002



The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012

Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008


Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002



The effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in the breath condensate of adults with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 113s
Year: 2002

The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005

The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

Investigation of nitric oxide level in the exhaled breath condensate in asthma and COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005

Elevated exhaled nitric oxide without acidification of exhaled breath condensate in patients with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 506s
Year: 2002

The effect of antioxidant therapy on nitric oxide metabolites in exhaled breath condensate in patients with pollen allergy and bronchial asthma
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III
Year: 2007


Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic disease
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008

Relationship between exhaled air temperature and exhaled nitric oxide in childhood asthma
Source: Eur Respir J 2002; 20: 108-111
Year: 2002



Superiority of hydrogen peroxide to exhaled nitric oxide as a marker of bronchial inflammation in asthmatic children
Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring
Year: 2008


Hydrogen peroxide in exhaled breath condensate and exhaled nitric oxide as non-invasive markers for childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Exhaled nitric oxide and lower airway involvement in persistent rhinitis
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 366s
Year: 2007

The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 304s
Year: 2004

Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Exhaled nitric oxide and carbon monoxide are not markers of disease activity in asthma patients on reducing doses of inhaled steroids: a longitudinal study
Source: Eur Respir J 2001; 18: Suppl. 33, 337s
Year: 2001